Cerenome, Inc. Announces Corporate Name and Nasdaq Ticker Change

What Happened Cerenome, Inc. (formerly Plus Therapeutics, Inc.) filed a Certificate of Amendment to its certificate of incorporation to change its corporate name to Cerenome, Inc., effective August 3, 2026. The company reported the change in a Form 8-K filed Aug 4, 2026 (Amendment filed July 30, 2026). In connection with the name change, the company’s common stock began trading on the Nasdaq Capital Market under the new ticker symbol "CNSY" at the opening of trading on August 3, 2026.

Key Details

• Amendment to the Amended and Restated Certificate of Incorporation filed July 30, 2026; effective August 3, 2026.
• Nasdaq trading symbol changed to CNSY; trading under the new symbol began at market open on August 3, 2026.
• No change to the company’s CUSIP; common stock par value remains $0.001 per share.
• The company’s updated bylaws reflecting the name change were filed as an exhibit to the Form 8-K.

Why It Matters A corporate name and ticker change are administrative but material for shareholders and market tracking: update brokerage/watchlist records to ensure continuous trading and accurate portfolio reporting. The filing indicates no change to the underlying shares or CUSIP, so there is no implied dilution or change to ownership rights from this action. For further details or the official amendment and bylaws, investors can review the exhibits to the company’s Aug 4, 2026 Form 8-K.